BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)
暂无分享,去创建一个
[1] B. Vargaftig,et al. Present concepts on the mechanisms of platelet aggregation. , 1981, Biochemical pharmacology.
[2] D. Hanahan,et al. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). , 1981, Biochimica et biophysica acta.
[3] L. Douste-Blazy,et al. Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets , 1981, Nature.
[4] F. Snyder,et al. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). , 1981, The Journal of biological chemistry.
[5] P. Henson,et al. Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil. , 1980, Journal of immunology.
[6] J. Benveniste,et al. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[7] F. Snyder,et al. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. , 1980, The Journal of biological chemistry.
[8] G. Camussi,et al. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation. , 1980, Prostaglandins.
[9] R. N. Pinckard,et al. Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit. , 1980, Journal of immunology.
[10] D. H. Namm,et al. Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. , 1980, Thrombosis research.
[11] C. Redeuilh,et al. Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline , 1980, FEBS letters.
[12] B. Vargaftig,et al. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. , 1980, European journal of pharmacology.
[13] F. Bussolino,et al. Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP. , 1980, Immunology.
[14] P. Henson,et al. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. , 1980, The American journal of pathology.
[15] F. Snyder,et al. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.
[16] D. Hanahan,et al. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.
[17] D. Hanahan,et al. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. , 1979, Journal of immunology.
[18] J. Cazenave,et al. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. , 1979, Laboratory investigation; a journal of technical methods and pathology.
[19] B. Vargaftig,et al. The role of platelet-activating factor in platelet aggregation , 1979, Nature.
[20] P. Cuatrecasas,et al. Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Mustard,et al. Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. , 1977, Blood.
[22] J. Cazenave,et al. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. , 1977, The Journal of laboratory and clinical medicine.
[23] R. Feinman,et al. Interrelations of platelet aggregation and secretion. , 1977, The Journal of clinical investigation.
[24] B. Vargaftig. Carrageenan and thrombin trigger prostaglandin synthetase‐independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors * , 1977, The Journal of pharmacy and pharmacology.
[25] J. Benveniste,et al. Structural analysis of purified platelet-activating factor by lipases , 1977, Nature.
[26] P. Henson. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion. , 1977, The Journal of clinical investigation.
[27] Henson Pm. Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response. , 1976 .
[28] Heathcote Jg. Letter: Multiple sclerosis. , 1975 .
[29] P. Kamoun,et al. AGGREGATION OF HUMAN PLATELETS BY PLATELET-ACTIVATING FACTOR , 1975, The Lancet.
[30] Robert A. Lewis,et al. The release of four mediators of immediate hypersensitivity from human leukemic basophils. , 1975, Journal of immunology.
[31] J. Benveniste,et al. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils , 1974, Nature.
[32] P. Henson,et al. LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS THE ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR , 1972 .
[33] A. G. Osler,et al. Destruction of rabbit platelets in the allergic response of sensitized leukocytes. II. Evidence for basophil involvement. , 1971, Journal of immunology.
[34] N. Zvaifler,et al. Antigen Induced Histamine Release from Platelets of Rabbits Producing Homologous PGA Antibody. , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[35] J. Riley. FUNCTIONAL SIGNIFICANCE OF HISTAMINE AND HEPARIN IN TISSUE MAST CELLS , 1963, Annals of the New York Academy of Sciences.